Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Pancreatic Cancer
NCT01838317Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2013
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in pancreatic adenocarcinoma (PDAC), sponsored by UT Southwestern Medical Center. Started May 2013; status: completed.
02
Drugs
pioglitazone
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT01838317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838317.